- Home
- CPAY vs TOI Comparison
CPAY vs TOI Comparison
Compare CPAY & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPAY
- TOI
- Stock Information
- Founded
- CPAY 1986
- TOI 2007
- Country
- CPAY United States
- TOI United States
- Employees
- CPAY N/A
- TOI N/A
- Industry
- CPAY EDP Services
- TOI Medical/Nursing Services
- Sector
- CPAY Technology
- TOI Health Care
- Exchange
- CPAY Nasdaq
- TOI Nasdaq
- Market Cap
- CPAY 24.6B
- TOI 266.8M
- IPO Year
- CPAY 2010
- TOI N/A
- Fundamental
- Price
- CPAY $324.97
- TOI $3.19
- Analyst Decision
- CPAY Buy
- TOI
- Analyst Count
- CPAY 14
- TOI 0
- Target Price
- CPAY $397.17
- TOI N/A
- AVG Volume (30 Days)
- CPAY 518.8K
- TOI 1.7M
- Earning Date
- CPAY 05-06-2025
- TOI 05-14-2025
- Dividend Yield
- CPAY N/A
- TOI N/A
- EPS Growth
- CPAY 6.08
- TOI N/A
- EPS
- CPAY 14.26
- TOI N/A
- Revenue
- CPAY $4,045,005,000.00
- TOI $403,152,000.00
- Revenue This Year
- CPAY $13.32
- TOI $23.95
- Revenue Next Year
- CPAY $10.44
- TOI N/A
- P/E Ratio
- CPAY $22.80
- TOI N/A
- Revenue Growth
- CPAY 6.68
- TOI 17.64
- 52 Week Low
- CPAY $247.10
- TOI $0.13
- 52 Week High
- CPAY $400.81
- TOI $3.50
- Technical
- Relative Strength Index (RSI)
- CPAY 45.20
- TOI 61.85
- Support Level
- CPAY $319.87
- TOI $2.82
- Resistance Level
- CPAY $335.00
- TOI $3.35
- Average True Range (ATR)
- CPAY 6.66
- TOI 0.37
- MACD
- CPAY -1.87
- TOI -0.00
- Stochastic Oscillator
- CPAY 13.45
- TOI 85.32
About CPAY Corpay Inc.
Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.